- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.53B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $4.31B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $20.01B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $20.19B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $6.06B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5.83B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $40.51B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $40.69B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.65B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $8.1B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $60.57B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $60.94B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 271.52K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $519.61M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $451.26M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.40 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.40 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $624.42M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $25M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$15.24M |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.01B |